Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.00795
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 20, 2018
Authors
Publisher
Frontiers Media SA